108 related articles for article (PubMed ID: 1103575)
1. Pipamperone (Dipiperon, R3345) in troublesome mental retardates: a double-blind placebo controlled cross-over study with long-term follow-up.
van Hemert JC
Acta Psychiatr Scand; 1975 Oct; 52(4):237-45. PubMed ID: 1103575
[TBL] [Abstract][Full Text] [Related]
2. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
Deberdt R
Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
[TBL] [Abstract][Full Text] [Related]
3. A retrospective evaluation of pipamperone (Dipiperon) in the treatment of behavioural deviations in severely mentally handicapped.
Haegeman J; Duyck F
Acta Psychiatr Belg; 1978; 78(2):392-8. PubMed ID: 354326
[TBL] [Abstract][Full Text] [Related]
4. Sleep disorders in patients with severe mental depression: double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon).
Ansoms C; Backer-Dierick GD; Vereecken JL
Acta Psychiatr Scand; 1977 Feb; 55(2):116-22. PubMed ID: 320830
[TBL] [Abstract][Full Text] [Related]
5. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
Van Renynghe de Voxvrie G; De Bie M
Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
[TBL] [Abstract][Full Text] [Related]
6. Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients.
Squelart P; Saravia J
Acta Psychiatr Belg; 1977; 77(2):284-93. PubMed ID: 906888
[TBL] [Abstract][Full Text] [Related]
7. [Pipamperone and the treatment of impulsive aggressive behaviour].
Klaassen AA
Tijdschr Psychiatr; 2008; 50(3):179-83. PubMed ID: 18324605
[TBL] [Abstract][Full Text] [Related]
8. Treating severe maladjustment with pipamperone (Dipiperon).
Noordhuizen GJ
Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
[TBL] [Abstract][Full Text] [Related]
9. [Clinical trial with R-3345].
Bastos O; Carvalho RG
J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
[No Abstract] [Full Text] [Related]
10. Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes.
Boettger S; Knöpfel S; Schubert M; Garcia Nuñez D; Plichta MM; Klaghofer R; Jenewein J
Swiss Med Wkly; 2017; 147():w14471. PubMed ID: 28750419
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone].
Fouks ; Mathis ; Gilbert ; Ferragu ; Houssait ; Lerno
Ann Med Psychol (Paris); 1966 Dec; 124(5):677-81. PubMed ID: 5973302
[No Abstract] [Full Text] [Related]
12. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
Madalena JC
Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
[No Abstract] [Full Text] [Related]
13. A double blind study with melperone and placebo in the treatment of chronic alcoholics.
Carlsson C; Gullberg B
Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):331-2. PubMed ID: 352974
[TBL] [Abstract][Full Text] [Related]
14. Comparison of SCH-12679 and thioridazine in aggressive mental retardates.
Elie R; Langlois Y; Cooper SF; Gravel G; Albert JM
Can J Psychiatry; 1980 Oct; 25(6):484-91. PubMed ID: 7417923
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin-induced diarrhoea treated with loperamide or diphenoxylate. A double-blind study.
Lange AP; Secher NJ; Amery W
Acta Med Scand; 1977; 202(6):449-54. PubMed ID: 339672
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of pipamperone from three different tablet formulations.
Potgieter GE; Groenewoud G; Jordaan PJ; Hundt HK; Schall R; Kummer M; Sewarte-Ross G
Arzneimittelforschung; 2002; 52(6):430-4. PubMed ID: 12109042
[TBL] [Abstract][Full Text] [Related]
17. Treatment of nausea and vomiting related to anti-cancerous multiple combination chemotherapy: results of two controlled studies.
Israel L; Rodary C
J Int Med Res; 1978; 6(3):235-40. PubMed ID: 348536
[TBL] [Abstract][Full Text] [Related]
18. Clastogenic effects of haloperidol in vivo and of haloperidol, droperidol, and pipamperone in vitro. A negative study.
van den Berghe H
Arzneimittelforschung; 1974 Dec; 24(12):2055-8. PubMed ID: 4615717
[No Abstract] [Full Text] [Related]
19. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
20. Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values.
Worrall EP; Moody JP; Naylor GJ
Br J Psychiatry; 1975 May; 126():464-8. PubMed ID: 1092398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
